Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mia Sydenham"'
Autor:
Francis Mussai, Carmela De Santo, Paul Cheng, Ian F. Thomas, Cono Ariti, Laura Upton, Ugo Scarpa, Victoria Stavrou, Mia Sydenham, Alan K. Burnett, Steven K. Knapper, Priyanka Mehta, Mary F. McMullin, Mhairi Copland, Nigel H. Russell, Mike Dennis
Publikováno v:
British Journal of Haematology. 200:573-578
Autor:
Francis, Mussai, Carmela, De Santo, Paul, Cheng, Ian F, Thomas, Cono, Ariti, Laura, Upton, Ugo, Scarpa, Victoria, Stavrou, Mia, Sydenham, Alan K, Burnett, Steven K, Knapper, Priyanka, Mehta, Mary F, McMullin, Mhairi, Copland, Nigel H, Russell, Mike, Dennis
Publikováno v:
British journal of haematologyREFERENCES.
The survival of acute myeloid leukaemia (AML) patients aged over 60 has been suboptimal historically, whether they are treated using hypomethylating agents, low-dose cytarabine (LDAC) or venetoclax-based regimens. Progress is being made, however, for
Autor:
Megan Othus, Ian Thomas, Xu Wang, Cono Ariti, Priyanka Mehta, Mia Sydenham, Robert K. Hills, Alan K. Burnett, Sucha Nand, Sarit Assouline, Laura C. Michaelis, Harry P. Erba, Nigel Russell, Kathleen F. Kerr, Roland B. Walter, Mike Dennis
Publikováno v:
Leukemialymphoma.
Autor:
Mary Frances McMullin, Ian Thomas, Priyanka Mehta, Francis Mussai, Nigel H. Russell, Cono Ariti, Laura Upton, Mhairi Copland, Robert Kerrin Hills, Steve Knapper, Alan K. Burnett, Mia Sydenham
Publikováno v:
Blood. 138:2355-2355
Background: Among patients with Acute Myeloid Leukaemia (AML) over the age of 60, a considerable number are not considered suitable for intensive remission-induction chemotherapy. Survival in these patients is poor, whether they are treated using hyp
Autor:
Cono Ariti, Harry P. Erba, Mia Sydenham, Sucha Nand, Alan K. Burnett, Megan Othus, Kathleen F. Kerr, Ian Thomas, Laura C. Michaelis, Michael Dennis, Xu Wang, Roland B. Walter, Sarit Assouline, Priyanka Mehta, Nigel H Russel, Robert Kerrin Hills
Publikováno v:
Blood. 138:220-220
Background: Therapeutic resistance and treatment tolerance vary greatly in patients with AML, likely due to the advanced age and genetic diversity in pharmacokinetics of those affected. Undoubtedly, tools to accurately predict outcomes of individual
Autor:
Cono Ariti, Alan K. Burnett, Priyanka Mehta, Michael Dennis, Laura Upton, Mhairi Copland, Robert Kerrin Hills, Ian Thomas, N Russell, Shahidul Islam, Mia Sydenham, Lars Kjeldsen
Publikováno v:
Blood. 138:1266-1266
Background: Many patients with Acute Myeloid Leukemia (AML) diagnosed after 60 years of age are not considered suitable for intensive remission induction chemotherapy, either due to co-morbidities or frailty associated with advanced age. Despite trea
Publikováno v:
Sydenham, M, Beardwood, J & Rimes, K A 2017, ' Beliefs about Emotions, Depression, Anxiety and Fatigue: A Mediational Analysis ', Behavioural and Cognitive Psychotherapy, vol. 45, no. 1, pp. 73-78 . https://doi.org/10.1017/S1352465816000199
Background: Beliefs that it is unacceptable to experience or express negative emotions have been found to be associated with various clinical problems. It is unclear how such beliefs, which could be viewed as a form of unhelpful perfectionism about e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7307075d5fae5d024a423a9ebbd1a70
https://kclpure.kcl.ac.uk/ws/files/52108342/Sydenham_2016_Beliefs_about_Emotions_Pre_print_version.pdf
https://kclpure.kcl.ac.uk/ws/files/52108342/Sydenham_2016_Beliefs_about_Emotions_Pre_print_version.pdf